BACKGROUND: Kidney function, expressed as glomerular filtration rate (GFR), is commonly estimated from serum creatinine (Scr) and, when decreased, may serve as a nonclassical risk factor for incident cardiovascular disease (CVD). The ability of estimated GFR (eGFR) to predict CVD events during 5-10 years of follow-up is assessed using data from the Strong Heart Study (SHS), a large cohort with a high prevalence of diabetes. METHODS: eGFRs were calculated with the abbreviated Modification of Diet in Renal Disease study (MDRD) and the Cockcroft-Gault (CG) equations. These estimates were compared in participants with normal and abnormal Scr. The association between eGFR and incident CVD was assessed. RESULTS: More subjects were labeled as having low eGFR (<60 ml/min per 1.73 m2) by the MDRD or CG equation, than by Scr alone. When Scr was in the normal range, both equations labeled similar numbers of participants as having low eGFRs, although concordance between the equations was poor. However, when Scr was elevated, the MDRD equation labeled more subjects as having low eGFR. Persons with low eGFR had increased risk of CVD. CONCLUSIONS: The MDRD and CG equations labeled more participants as having decreased GFR than did Scr alone. Decreased eGFR was predictive of CVD in this American Indian population with a high prevalence of obesity and type 2 diabetes mellitus.
BACKGROUND: Kidney function, expressed as glomerular filtration rate (GFR), is commonly estimated from serum creatinine (Scr) and, when decreased, may serve as a nonclassical risk factor for incident cardiovascular disease (CVD). The ability of estimated GFR (eGFR) to predict CVD events during 5-10 years of follow-up is assessed using data from the Strong Heart Study (SHS), a large cohort with a high prevalence of diabetes. METHODS: eGFRs were calculated with the abbreviated Modification of Diet in Renal Disease study (MDRD) and the Cockcroft-Gault (CG) equations. These estimates were compared in participants with normal and abnormal Scr. The association between eGFR and incident CVD was assessed. RESULTS: More subjects were labeled as having low eGFR (<60 ml/min per 1.73 m2) by the MDRD or CG equation, than by Scr alone. When Scr was in the normal range, both equations labeled similar numbers of participants as having low eGFRs, although concordance between the equations was poor. However, when Scr was elevated, the MDRD equation labeled more subjects as having low eGFR. Persons with low eGFR had increased risk of CVD. CONCLUSIONS: The MDRD and CG equations labeled more participants as having decreased GFR than did Scr alone. Decreased eGFR was predictive of CVD in this American Indian population with a high prevalence of obesity and type 2 diabetes mellitus.
Authors: Elisa T Lee; Thomas K Welty; Linda D Cowan; Wenyu Wang; Dorothy A Rhoades; Richard Devereux; Oscar Go; Richard Fabsitz; Barbara V Howard Journal: Diabetes Care Date: 2002-01 Impact factor: 19.112
Authors: James L Januzzi; Steven M Snapinn; Peter M DiBattiste; Ik-Kyung Jang; Pierre Theroux Journal: Circulation Date: 2002-05-21 Impact factor: 29.690
Authors: Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; E Magnus Ohman; David R Holmes Journal: Circulation Date: 2002-08-20 Impact factor: 29.690
Authors: Anuja Mittalhenkle; Catherine O Stehman-Breen; Michael G Shlipak; Linda F Fried; Ronit Katz; Bessie A Young; Stephen Seliger; Daniel Gillen; Anne B Newman; Bruce M Psaty; David Siscovick Journal: Clin J Am Soc Nephrol Date: 2008-02-06 Impact factor: 8.237
Authors: Jiaqiong Xu; Elisa T Lee; Leif E Peterson; Richard B Devereux; Everett R Rhoades; Jason G Umans; Lyle G Best; William J Howard; Jaya Paranilam; Barbara V Howard Journal: J Clin Endocrinol Metab Date: 2012-07-16 Impact factor: 5.958
Authors: Jonathan D Newman; Ana Navas-Acien; Chin-Chi Kuo; Eliseo Guallar; Barbara V Howard; Richard R Fabsitz; Richard B Devereux; Jason G Umans; Kevin A Francesconi; Walter Goessler; Lyle T Best; Maria Tellez-Plaza Journal: Am J Epidemiol Date: 2016-11-03 Impact factor: 4.897
Authors: Maria Tellez-Plaza; Eliseo Guallar; Richard R Fabsitz; Barbara V Howard; Jason G Umans; Kevin A Francesconi; Walter Goessler; Richard B Devereux; Ana Navas-Acien Journal: Circ Cardiovasc Qual Outcomes Date: 2013-11
Authors: Nawar M Shara; Hong Wang; Mihriye Mete; Yaman Rai Al-Balha; Nameer Azalddin; Elisa T Lee; Nora Franceschini; Stacey E Jolly; Barbara V Howard; Jason G Umans Journal: Am J Kidney Dis Date: 2012-07-25 Impact factor: 8.860
Authors: Agata L Gava; Flavia Ps Freitas; Camille M Balarini; Elisardo C Vasquez; Silvana S Meyrelles Journal: Int J Physiol Pathophysiol Pharmacol Date: 2012-09-20
Authors: V Saroja Voruganti; Nora Franceschini; Karin Haack; Sandra Laston; Jean W MacCluer; Jason G Umans; Anthony G Comuzzie; Kari E North; Shelley A Cole Journal: Eur J Hum Genet Date: 2013-12-04 Impact factor: 4.246
Authors: Maria Tellez-Plaza; Eliseo Guallar; Barbara V Howard; Jason G Umans; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Richard B Devereux; Ana Navas-Acien Journal: Epidemiology Date: 2013-05 Impact factor: 4.822
Authors: Nora Franceschini; Nawar M Shara; Hong Wang; V Saroja Voruganti; Sandy Laston; Karin Haack; Elisa T Lee; Lyle G Best; Jean W Maccluer; Barbara J Cochran; Thomas D Dyer; Barbara V Howard; Shelley A Cole; Kari E North; Jason G Umans Journal: Kidney Int Date: 2012-04-18 Impact factor: 10.612